Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?

Aromatase Inhibitors in Breast Cancer

Smith, I. E., & Dowsett, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023246 · Cited by 907 · see citing works

Aromatase—a brief overview

Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773 · see citing works

Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study

Geisler, J., Haynes, B., Anker, G., Dowsett, M., & Lønning, P. E. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.751 · Cited by 604 · see citing works

Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment

Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.6 · Cited by 531 · see citing works

Steroid sulfatase: molecular biology, regulation, and inhibition

Reed, M. J., Purohit, A., Woo, L. W. L., Newman, S. P., & Potter, B. V. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0003 · Cited by 524 · see citing works

Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT

Chia, S., Gradishar, W. J., Mauriac, L., Bines, J., Amant, F. C., Federico, M. H. H., Fein, L. E., Romieu, G., Buzdar, A. U., Robertson, J. F. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5822 · Cited by 514 · see citing works

In Situ Estrogen Production via the Estrone Sulfatase Pathway in Breast Tumors: Relative Importance versus the Aromatase Pathway*

Santner, S. J., Feil, P. D., & Santen, R. J. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-29 · Cited by 407 · see citing works

In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients.

Geisler, J., King, N. C., Anker, G. B., Ornati, G., di Salle, E., Lønning, P. E., & Dowsett, M. (1998) · PubMed · Cited by 314 · see citing works

Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells

Masamura, S., Santner, S. J., Heitjan, D. F., & Santen, R. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.10.7559875 · Cited by 307 · see citing works

Phase I Study of STX 64 (667 Coumate) in Breast Cancer Patients: The First Study of a Steroid Sulfatase Inhibitor

Stanway, S. J., Purohit, A., Woo, L. W. L., Sufi, S., Vigushin, D. M., Ward, R. E., Wilson, R. H., Stanczyk, F. Z., Dobbs, N. A., Kulinskaya, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1996 · Cited by 240 · see citing works

Human Aromatase: cDNA Cloning, Southern Blot Analysis, and Assignment of the Gene to Chromosome 15

Chen, S., Besman, M. J., Sparkes, R. S., Zollman, S., Klisak, I. J., Mohandas, T. K., Hall, P. F., & Shively, J. E. (1988) · DNA · doi:10.1089/dna.1988.7.27 · Cited by 231 · see citing works

Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer

Pasqualini, J. R., & Chetrite, G. S. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.02.007 · Cited by 194 · see citing works

Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

Suzuki, T., Nakata, T., Miki, Y., Kaneko, C., Moriya, T., Ishida, T., Akinaga, S., Hirakawa, H., Kimura, M., & Sasano, H. (2003) · PubMed · Cited by 185 · see citing works

Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer.

Utsumi, T., Yoshimura, N., Takeuchi, S., Ando, J., MARUTA, M., Maeda, K., & Harada, N. (1999) · PubMed · Cited by 144 · see citing works

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

Geisler, J., Helle, H., Ekse, D., Duong, N. K., Evans, D. B., Nordbø, Y., Aas, T., & Lønning, P. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5221 · Cited by 140 · see citing works

Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators

Geisler, J. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00364-9 · Cited by 133 · see citing works

Human sulfatases: a structural perspective to catalysis

Ghosh, D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7175-y · Cited by 123 · see citing works

Design and validation of specific inhibitors of 17 -hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis

Day, J. M., Tutill, H. J., Purohit, A., & Reed, M. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0042 · Cited by 123 · see citing works

Aromatase Inhibition: Translation into a Successful Therapeutic Approach

Geisler, J., & Lønning, P. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2187 · Cited by 116 · see citing works

17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer

Day, J. M., Foster, P., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23350 · Cited by 107 · see citing works

Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma

Tseng, L., Mazella, J., Lee, L. Y., & Stone, M. L. (1983) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(83)91116-0 · Cited by 99 · see citing works

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status

Lønning, P. E., Helle, H., Duong, N. K., Ekse, D., Aas, T., & Geisler, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.06.005 · Cited by 98 · see citing works

Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors

Billich, A., Nußbaumer, P., & Lehr, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00077-7 · Cited by 96 · see citing works

Intratumoral Estrogen Disposition in Breast Cancer

Haynes, B. P., Straume, A. H., Geisler, J., A’Hern, R., Helle, H., Smith, I. E., Lønning, P. E., & Dowsett, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2481 · Cited by 96 · see citing works

In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE.

Purohit, A., Woo, L. W. L., Potter, B. V. L., & Reed, M. J. (2000) · PubMed · Cited by 90 · see citing works

Design, Synthesis, and Biological Evaluation of (Hydroxyphenyl)naphthalene and -quinoline Derivatives: Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases

Frotscher, M., Ziegler, E., Marchais‐Oberwinkler, S., Kruchten, P., Neugebauer, A., Fetzer, L., Scherer, C., Müller‐Vieira, U., Messinger, J., Thole, H., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701447v · Cited by 89 · see citing works

Oestrogen producing enzymes and mammary carcinogenesis: a review

Subramanian, A., Salhab, M., & Mokbel, K. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9788-0 · Cited by 82 · see citing works

Dual Aromatase−Steroid Sulfatase Inhibitors

Woo, L. W. L., Bubert, C., Sutcliffe, O. B., Smith, A., Chander, S. K., Mahon, M. F., Purohit, A., Reed, M. J., & Potter, B. V. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061462b · Cited by 80 · see citing works

Highly Potent First Examples of Dual Aromatase−Steroid Sulfatase Inhibitors based on a Biphenyl Template

Woo, L. W. L., Jackson, T., Putey, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901705h · Cited by 79 · see citing works

17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production

Aka, J. A., Mazumdar, M., Chen, C., Poirier, D., & Lin, S. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0468 · Cited by 78 · see citing works

17β-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor–Positive Breast Cancer

Jansson, A., Gunnarsson, C., Cohen, M., Sivik, T., & Stål, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1448 · Cited by 73 · see citing works

First Dual Aromatase-Steroid Sulfatase Inhibitors

Woo, L. W. L., Sutcliffe, O. B., Bubert, C., Grasso, A., Chander, S. K., Purohit, A., Reed, M. J., & Potter, B. V. L. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034033b · Cited by 69 · see citing works

Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors

Laplante, Y., Rancourt, C., & Poirier, D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.026 · Cited by 68 · see citing works

Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma

Evans, T., Rowlands, M. G., Law, M. G., & Coombes, R. C. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.101 · Cited by 60 · see citing works

Dual aromatase–sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity

Jackson, T., Woo, L. W. L., Trusselle, M. N., Chander, S. K., Purohit, A., Reed, M. J., & Potter, B. V. L. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b707768h · Cited by 60 · see citing works

Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme

Husen, B., Huhtinen, K., POUTANEN, M. H., Kangas, L., Messinger, J., & Thole, H. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.042 · Cited by 56 · see citing works

In vivo Efficacy of STX213, A Second-Generation Steroid Sulfatase Inhibitor, for Hormone-Dependent Breast Cancer Therapy

Foster, P., Newman, S. P., Chander, S. K., Stengel, C., Jhalli, R., Woo, L. W. L., Potter, B. V. L., Reed, M. J., & Purohit, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0632 · Cited by 56 · see citing works

Hormonal therapy for postmenopausal breast cancer: the science of sequencing

Miller, W. R., Bartlett, J. M. S., Canney, P. A., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9369-7 · Cited by 45 · see citing works

Increased estrogen sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients

Chanplakorn, N., Chanplakorn, P., Suzuki, T., Ono, K., Chan, M. S. M., Miki, Y., Saji, S., Ueno, T., Toi, M., & Sasano, H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0785-3 · Cited by 44 · see citing works

Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer

Aka, J. A., Mazumdar, M., & Lin, S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.042 · Cited by 42 · see citing works

Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography

Woo, L. W. L., Fischer, D. S., Sharland, C. M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0195 · Cited by 41 · see citing works

A letrozole-based dual aromatase–sulphatase inhibitor with in vivo activity

Wood, P. M., Woo, L. W. L., Humphreys, A., Chander, S. K., Purohit, A., Reed, M. J., & Potter, B. V. L. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.028 · Cited by 41 · see citing works

A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor

Foster, P., Chander, S. K., Newman, S. P., Woo, L. W. L., Sutcliffe, O. B., Bubert, C., Zhou, D., Chen, S., Potter, B. V. L., Reed, M. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1027 · Cited by 41 · see citing works

Regulation of oestradiol 17β hydroxysteroid dehydrogenase in breast tissues: The role of growth factors

Reed, M. J., Singh, A., Ghilchik, M. W., Coldham, N. G., & Purohit, A. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90027-3 · Cited by 38 · see citing works

17β-Hydroxysteroid dehydrogenase Type 1 and Type 2: Association between mRNA expression and activity in cell lines

Day, J. M., Tutill, H. J., Newman, S. P., Purohit, A., Lawrence, H. R., Vicker, N., Potter, B. V. L., & Reed, M. J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.01.011 · Cited by 35 · see citing works

Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer

Foster, P., Chander, S. K., Parsons, M. F. C., Newman, S. P., Woo, L. W. L., Potter, B. V. L., Reed, M. J., & Purohit, A. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9769-3 · Cited by 34 · see citing works

A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models

Ishida, H., Nakata, T., Suzuki, M., Shiotsu, Y., Tanaka, H., Sato, N., Terasaki, Y., Takebayashi, M., Anazawa, H., Murakata, C., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9495-x · Cited by 31 · see citing works

Localization of estrone sulfatase in human breast carcinomas

Saeki, T., Takashima, S., Sasaki, H., Hanai, N., & Salomon, D. S. (1999) · Breast Cancer · doi:10.1007/bf02966449 · Cited by 30 · see citing works

Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates

Numazawa, M., Tominaga, T., Watari, Y., & Tada, Y. (2006) · Steroids · doi:10.1016/j.steroids.2005.12.004 · Cited by 25 · see citing works

Aromatase inhibitors as adjuvant treatment of breast cancer

Geisler, J., & Lønning, P. E. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.05.005 · Cited by 22 · see citing works

Steroid Biosynthetic Enzymes: 17 β Hydroxysteroid Dehydrogenase

ISOMAA, V. V., Ghersevich, S. A., Mäentausta, O., Peltoketo, H., POUTANEN, M. H., & Vihko, R. (1993) · Annals of Medicine · doi:10.3109/07853899309147864 · Cited by 22 · see citing works

A Phase I Dose Escalation Study of Steroid Sulfatase Inhibitor BN83495/STX64 in Postmenopausal Women with ER Positive Breast Cancer.

Coombes, R. C., Schmid, P., Isambert, N., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-4097 · Cited by 14 · see citing works

6-[2-(Adamantylidene)-hydroxybenzoxazole]-O-sulfamate, a steroid sulfatase inhibitor for the treatment of androgen- and estrogen-dependent diseases

Billich, A., Meingassner, J. G., Nußbaumer, P., Desrayaud, S., Lam, C., Winiski, A. P., & Schreiner, E. P. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.06.004 · Cited by 12 · see citing works

Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity (vol 5, pg 2940, 2007)

Jackson, T., Lwl., W., Trusselle, M. N., Chander, S. K., Purohit, A., Reed, M., & Potter, B. V. L. (2007) · Organic & Biomolecular Chemistry · Cited by 6 · see citing works

SR16157 Is a Potent Dual-Acting Inhibitor of Estrogen Biosynthesis and Estrogen Receptor.

Sambucetti, L. C., Green, C., Rausch, L. L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-5124 · Cited by 2 · see citing works

The Regulation of Steroid Action by Sulfation and Desulfation

Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419 · see citing works

Intracrine androgen biosynthesis, metabolism and action revisited

Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217 · see citing works

Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers

Purohit, A., & Foster, P. A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0266 · Cited by 126 · see citing works

New assay for steroid sulfatase (EC 3.1.6.2) and its application for studies of human placental and skin sulfatase

Rabe, T., Kiesel, L., Radke, G., et al. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90134-1 · Cited by 7 · see citing works

Human placental steroid-sulfatase. Kinetics of the in-vitro hydrolysis of dehydroepiandrosterone 3-sulfate and of 16 alpha-hydroxydehydroepiandrosterone 3-sulfate.

DIBBELT, L., & Kuss, E. (1983) · PubMed · Cited by 11 · see citing works

The Hydrolysis of Estrone Sulfate and Dehydroepiandrosterone Sulfate by MCF-7 Human Breast Cancer Cells*

MacIndoe, J. H., Woods, G. R., Jeffries, L., et al. (1988) · Endocrinology · doi:10.1210/endo-123-3-1281 · Cited by 91 · see citing works

In SituSteroid Sulfatase Activity in Human Epithelial Carcinoma Cells of Vaginal, Ovarian, and Endometrial Origin*

Milewich, L., & Porter, J. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-164 · Cited by 26 · see citing works

Elevated steroid sulfatase expression in breast cancers

Utsumi, T., Yoshimura, N., Takeuchi, S., MARUTA, M., Maeda, K., & Harada, N. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00060-1 · Cited by 108 · see citing works